Yeast has long been a cheap and abundant ingredient in bread and beer and thanks to its unique chemical properties, it can now be used in diagnostic technologies that rival PCR testing for speed and sensitivity.
As we close the book on 2022 it is time to look at how far the AIBN has come during the year, and how we are setting ourselves up for an even bigger 2023.
University of Queensland researchers have pioneered a new chemical process to manufacture the molecules that are the building blocks for lifesaving medicines, vaccines and energy storage materials.
AIBN researchers have developed a diagnostic device, called an Immuno-storm chip, that could identify which cancer and COVID-19 patients are at risk of a potentially lethal ‘cytokine storm’.
